How much is Elation Health worth in 2026?

Elation Health has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Elation Health raised?

Elation Health has raised N/A in total funding across 1 funding rounds.

Elation Health

Medical Records Systems

Elation Health valuation and funding history | Last updated: March 21, 2012 | 1 funding rounds

Current Valuation

N/A

As of March 21, 2012

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$3.5M

Last Funding

Mar 2012

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 21, 2012	Early Stage VC (Series A)	$3.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Elation Health is currently valued at N/A as of March 21, 2012.

Track Elation Health Valuation Updates

Get notified when Elation Health raises new funding or valuation changes

Explore More Data

Detailed analysis for Elation Health

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Elation Health's valuation history, funding rounds, and growth metrics.

No credit card required

What is Elation Health Worth in 2026?

Elation Health is a leading private company in the Medical Records Systems sector. Track Elation Health's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Elation Health Valuation is Determined

Private company valuations like Elation Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.